RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
59. Structural characterization of a biologically active human Lipocortin 1 expressed in Escherichia coli
1992-01-01 Arcone, R.; Arpaia, G.; Ruoppolo, M.; Malorni, A.; Marino, G.; Ialenti, A.; DI ROSA, M.; Ciliberto, G
A bipartite activation domain is responsible for the activity of transcription factor HNF1/LFB1 in cells of hepatic and non-hepatic origin
1993-01-01 Toniatti, C.; Monaci, P.; Nicosia, A.; Cortese, R.; Ciliberto, G
A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phsphatase (SEAP)
1994-01-01 Gregory, B.; Savino, R; Ciliberto, G.
A fast and sensitive colorimetric assay for IL-6 on hepatoma cells based on the production of a secreted form of alkaline phosphatase (SEAP)
1994-01-01 Gregory, B.; Savino, R.; Ciliberto, G
A federated learning system for precision oncology in Europe: DigiONE
2024-01-01 Mahon, Piers; Chatzitheofilou, Ismini; Dekker, Andre; Fernández, Xosé; Hall, Geoff; Helland, Aslaug; Traverso, Alberto; Van Marcke, Cedric; Vehreschild, Janne; Ciliberto, Gennaro; Tonon, Giovanni
A functionally orthogonal estrogen Receptor-based transcription switch Tightly controlled by a non-steroid synthetic ligand
2005-01-01 Gallinari, P.; Lahm, A.; Koch, U.; Paolini, C.; Nardi, Mc.; LAMARTINA S, .; Roscilli, G.; Kinzel, O.; Fattori, D.; Muraglia, E.; Toniatti, C.; Cortese, R.; De, Francesco; Ciliberto, G
A general method to select for M13 clones carrying base pair substitution mutants constructed in vitro
1983-01-01 Traboni, C.; Cortese, R.; Ciliberto, G; Cesareni, G.
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope
2005-01-01 Miller, Md; Geleziunas, R; Bianchi, E; Lennard, S; Hrin, R; Zhang, H; Lu, M; An, Z; Ingallinella, P; Finotto, M; Mattu, M; Finnefrock, A; Bramhill, D; Cook, J; Eckert, D; Hampton, R; Patel, M; Jarantow, S; Joyce, J; Ciliberto, G; Cortese, R; Lu, P; Strohl, W; Schleif, W; Mcelhaugh, M; Lane, S; Lloyd, C; Lowe, D; Osburne, J; Vaughan, T; Emini, E; Barbato, G; Kim, Ps; Hazuda, D; Shiver, J; Pessi, A.
A METHODOLOGY FOR SELECTING SUPERAGONISTS, ANTAGONISTS AND SUPERANTAGONISTS OF HORMONES WHOSE RECEPTOR COMPLEX INCLUDES GP 130
1995-01-01 Savino, R; Lahm, A; Ciliberto, G
A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave?
2020-01-01 Silvestris, N.; Apolone, G.; Botti, G.; Ciliberto, G.; Costantini, M.; De Paoli, P.; Franceschi, S.; Opocher, G.; Paradiso, A.; Pronzato, P.; Sgambato, A.; De Maria, R.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
59. Structural characterization of a biologically active human Lipocortin 1 expressed in Escherichia coli | 1-gen-1992 | Arcone, R.; Arpaia, G.; Ruoppolo, M.; Malorni, A.; Marino, G.; Ialenti, A.; DI ROSA, M.; Ciliberto, G | |
A bipartite activation domain is responsible for the activity of transcription factor HNF1/LFB1 in cells of hepatic and non-hepatic origin | 1-gen-1993 | Toniatti, C.; Monaci, P.; Nicosia, A.; Cortese, R.; Ciliberto, G | |
A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phsphatase (SEAP) | 1-gen-1994 | Gregory, B.; Savino, R; Ciliberto, G. | |
A fast and sensitive colorimetric assay for IL-6 on hepatoma cells based on the production of a secreted form of alkaline phosphatase (SEAP) | 1-gen-1994 | Gregory, B.; Savino, R.; Ciliberto, G | |
A federated learning system for precision oncology in Europe: DigiONE | 1-gen-2024 | Mahon, Piers; Chatzitheofilou, Ismini; Dekker, Andre; Fernández, Xosé; Hall, Geoff; Helland, Aslaug; Traverso, Alberto; Van Marcke, Cedric; Vehreschild, Janne; Ciliberto, Gennaro; Tonon, Giovanni | |
A functionally orthogonal estrogen Receptor-based transcription switch Tightly controlled by a non-steroid synthetic ligand | 1-gen-2005 | Gallinari, P.; Lahm, A.; Koch, U.; Paolini, C.; Nardi, Mc.; LAMARTINA S, .; Roscilli, G.; Kinzel, O.; Fattori, D.; Muraglia, E.; Toniatti, C.; Cortese, R.; De, Francesco; Ciliberto, G | |
A general method to select for M13 clones carrying base pair substitution mutants constructed in vitro | 1-gen-1983 | Traboni, C.; Cortese, R.; Ciliberto, G; Cesareni, G. | |
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope | 1-gen-2005 | Miller, Md; Geleziunas, R; Bianchi, E; Lennard, S; Hrin, R; Zhang, H; Lu, M; An, Z; Ingallinella, P; Finotto, M; Mattu, M; Finnefrock, A; Bramhill, D; Cook, J; Eckert, D; Hampton, R; Patel, M; Jarantow, S; Joyce, J; Ciliberto, G; Cortese, R; Lu, P; Strohl, W; Schleif, W; Mcelhaugh, M; Lane, S; Lloyd, C; Lowe, D; Osburne, J; Vaughan, T; Emini, E; Barbato, G; Kim, Ps; Hazuda, D; Shiver, J; Pessi, A. | |
A METHODOLOGY FOR SELECTING SUPERAGONISTS, ANTAGONISTS AND SUPERANTAGONISTS OF HORMONES WHOSE RECEPTOR COMPLEX INCLUDES GP 130 | 1-gen-1995 | Savino, R; Lahm, A; Ciliberto, G | |
A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave? | 1-gen-2020 | Silvestris, N.; Apolone, G.; Botti, G.; Ciliberto, G.; Costantini, M.; De Paoli, P.; Franceschi, S.; Opocher, G.; Paradiso, A.; Pronzato, P.; Sgambato, A.; De Maria, R. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 491
- 1 Contributo su Rivista::1.1 Arti... 490
- 6 Brevetti 29
- 6 Brevetti::6.1 Brevetto 29
- 2 Contributo in Volume 24
- 2 Contributo in Volume::2.1 Contr... 24
- 4 Contributo in Atti di Convegno ... 8
- 4 Contributo in Atti di Convegno ... 4
- 4 Contributo in Atti di Convegno ... 3
- 5 Altro 3
- 5 Altro::5.12 Altro 3
- 1 Contributo su Rivista::1.5 Abst... 1
- 4 Contributo in Atti di Convegno ... 1
Data di pubblicazione
- 2020 - 2024 129
- 2010 - 2019 172
- 2000 - 2009 96
- 1990 - 1999 115
- 1980 - 1989 42
- 1978 - 1979 1
Editore
- Oxford University Press 2
- ELSEVIER SCIENCE PUBLISHER B.V. 1
- IntechOpen 1
- IRL press at Oxford University Press 1
- Marcel Dekker, Inc. 1
- Società Editrice Romana 1
- Società Editrice Universo 1
- Springer, Boston, MA 1
- Taylor & Francis 1
Rivista
- JOURNAL OF TRANSLATIONAL MEDICINE 35
- JOURNAL OF EXPERIMENTAL & CLINICA... 24
- EMBO JOURNAL 21
- CANCERS 14
- ONCOTARGET 14
- HUMAN GENE THERAPY 12
- NUCLEIC ACIDS RESEARCH 12
- PROCEEDINGS OF THE NATIONAL ACADE... 12
- JOURNAL OF CELLULAR PHYSIOLOGY 10
- CELL DEATH & DISEASE 8
Keyword
- Humans 19
- COVID-19 18
- SARS-CoV-2 14
- Female 10
- Viral 9
- Aged 7
- Antibodies 7
- Immunotherapy 7
- Melanoma 7
- Male 6
Lingua
- eng 468
- ita 8
- ger 1
Accesso al fulltext
- no fulltext 554
- reserved 1